About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Financial Report for Half Year ended 30 June 2014

August 27, 2014

Click here to read more

Post navigation

Phosphagenics Completes First IND Enabling Study for TPM Oxymorphone Patch

Equity Capital Raising Placement of New Shares

Related Posts

Quarterly Activities Report and 4C – to 31 March 2023

April 28, 2023May 20, 2023

June 2017 Half Year Financial Report and Appendix 4D

September 1, 2017

2015 Annual Report

April 15, 2016

Recent Posts

MEDIA | Ausbiz
March 7, 2025
March 2025 | Investor Webinar
March 6, 2025
MEDIA | 180 Markets
March 5, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.